Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Clarus Therapeutics Holdings, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 338K | Dec 12, 2021 | Direct | ||
Clarus Therapeutics Holdings, Inc. | Chief Executive Officer, Director | Common Stock | 140K | Dec 12, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRXT | Clarus Therapeutics Holdings, Inc. | Dec 12, 2021 | 2 | $0 | 4 | Dec 14, 2021 | Chief Executive Officer, Director |
CRXT | Clarus Therapeutics Holdings, Inc. | Sep 9, 2021 | 1 | $0 | 4 | Sep 13, 2021 | Chief Executive Officer, Director |
CRXT | Clarus Therapeutics Holdings, Inc. | Sep 9, 2021 | 0 | $0 | 3 | Sep 13, 2021 | Chief Executive Officer, Director |